FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2195-2197 November 17, 2005 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Tanabe, K. K. PubMed Citation

To the Editor: Tanabe et al. (July 28 issue)¹provide an excellent example of the multidisciplinary decision making required in the case of a typical patient with hepatocellular carcinoma. Although radioactive yttrium-90 microspheres delivered through the hepatic artery were discussed as a treatment option, external-beam radiation was not. Historically, radiation therapy has played a minor role in the treatment of hepatocellular carcinoma, primarily because of the low tolerance of the whole liver to radiation. However, technological advances in tumor imaging, conformal-radiation planning, and radiation delivery have facilitated the safe use of high-dose radiotherapy for focal hepatocellular carcinomas, including tumors unsuitable . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.